Health Alliance International: A COVID-19 Information Hub

Health Alliance International (HAI), a center of the University of Washington Department of Global Health, has launched their spin on a COVID information hub. The hub is providing updates on the pandemic in Mozambique, Timor-Leste, and Côte d’Ivoire, while also highlighting the adaptation and resilience of health workers and resource-limited health systems. 

Amid Hydroxychloroquine Uproar, Real Studies of Drug Are Suffering (New York Times, quotes Christine Johnston)

President Trump’s enthusiastic embrace of a malaria drug that he now says he takes daily — and the resulting uproar in the news media — appears to be interfering with legitimate scientific research into whether the medicine might work to prevent coronavirus infection or treat the disease in its early stages.

COVID-19 Raises Risk for Women Who are Obese and Pregnant (UW Medicine Newsroom, quotes Kristina Adams Waldorf and Erica Lokken)

The novel coronavirus can severely affect pregnant women who are overweight or obese before becoming pregnant, new research suggests.

Published today by the American Journal of Obstetrics and Gynecology, the findings show that women who contract the virus may have a higher incidence of preterm birth.

Global Health Professor Receives Grant to Develop Antigen-Based COVID-19 Test

With a new $765,120 grant, Global Health professor Paul Drain will lead a study to develop an antigen-based COVID-19 test – as well as evaluate PCR-based tests and immunological assays – to be used at the point of care. This grant, sponsored by the Bill and Melinda Gates Foundation, is titled “Developing and Evaluating Point-of-Care Antigen and Immunoassays for COVID-19 and Cytokine Release Syndrome among people being screened for SARS-CoV-2 infection in Seattle”.

Pages